Why evolution designed us to die fast, & how we can change that – Jacob Kimmel

Why evolution designed us to die fast, & how we can change that – Jacob Kimmel – Dwarkesh Podcast

Mentioned

Bullish

NEWLIMIT— NewLimit's innovative approach to drug discovery, focusing on transcription factors, could lead to rapid medicine development and breakthrough products.
BIOTECH— The biotech sector shows promise due to its dominant role in early drug discovery and potential for increased revenue per medicine.
HC— The healthcare sector shows potential for growth due to increasing efficiency in pharmaceuticals and a shift towards preventative medicine, which could reduce overall costs.
LLY— Eli Lilly's innovative approach with Incredimimetics and the launch of Lilly Direct demonstrates the company's potential for growth in the pharmaceutical sector.

Not investment advice.